Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465860350> ?p ?o ?g. }
- W2465860350 endingPage "829" @default.
- W2465860350 startingPage "819" @default.
- W2465860350 abstract "Approximately 75% of objective responses to anti-programmed death 1 (PD-1) therapy in patients with melanoma are durable, lasting for years, but delayed relapses have been noted long after initial objective tumor regression despite continuous therapy. Mechanisms of immune escape in this context are unknown.We analyzed biopsy samples from paired baseline and relapsing lesions in four patients with metastatic melanoma who had had an initial objective tumor regression in response to anti-PD-1 therapy (pembrolizumab) followed by disease progression months to years later.Whole-exome sequencing detected clonal selection and outgrowth of the acquired resistant tumors and, in two of the four patients, revealed resistance-associated loss-of-function mutations in the genes encoding interferon-receptor-associated Janus kinase 1 (JAK1) or Janus kinase 2 (JAK2), concurrent with deletion of the wild-type allele. A truncating mutation in the gene encoding the antigen-presenting protein beta-2-microglobulin (B2M) was identified in a third patient. JAK1 and JAK2 truncating mutations resulted in a lack of response to interferon gamma, including insensitivity to its antiproliferative effects on cancer cells. The B2M truncating mutation led to loss of surface expression of major histocompatibility complex class I.In this study, acquired resistance to PD-1 blockade immunotherapy in patients with melanoma was associated with defects in the pathways involved in interferon-receptor signaling and in antigen presentation. (Funded by the National Institutes of Health and others.)." @default.
- W2465860350 created "2016-07-22" @default.
- W2465860350 creator A5001016649 @default.
- W2465860350 creator A5001061706 @default.
- W2465860350 creator A5011802426 @default.
- W2465860350 creator A5016063312 @default.
- W2465860350 creator A5017076927 @default.
- W2465860350 creator A5022247782 @default.
- W2465860350 creator A5023066362 @default.
- W2465860350 creator A5028356747 @default.
- W2465860350 creator A5029587873 @default.
- W2465860350 creator A5031948300 @default.
- W2465860350 creator A5036776132 @default.
- W2465860350 creator A5039301683 @default.
- W2465860350 creator A5043550728 @default.
- W2465860350 creator A5047604077 @default.
- W2465860350 creator A5048318133 @default.
- W2465860350 creator A5056069631 @default.
- W2465860350 creator A5058453474 @default.
- W2465860350 creator A5062326140 @default.
- W2465860350 creator A5062344802 @default.
- W2465860350 creator A5063377246 @default.
- W2465860350 creator A5067826298 @default.
- W2465860350 creator A5072594542 @default.
- W2465860350 creator A5074516552 @default.
- W2465860350 creator A5074681719 @default.
- W2465860350 creator A5081227531 @default.
- W2465860350 creator A5081677088 @default.
- W2465860350 creator A5082742595 @default.
- W2465860350 creator A5083745558 @default.
- W2465860350 creator A5086280182 @default.
- W2465860350 date "2016-09-01" @default.
- W2465860350 modified "2023-10-15" @default.
- W2465860350 title "Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma" @default.
- W2465860350 cites W1423342398 @default.
- W2465860350 cites W1511743510 @default.
- W2465860350 cites W1521367633 @default.
- W2465860350 cites W1524531954 @default.
- W2465860350 cites W1572267688 @default.
- W2465860350 cites W1927075449 @default.
- W2465860350 cites W1990675339 @default.
- W2465860350 cites W2019607817 @default.
- W2465860350 cites W2026318599 @default.
- W2465860350 cites W2032211985 @default.
- W2465860350 cites W2039123767 @default.
- W2465860350 cites W2046972425 @default.
- W2465860350 cites W2066671159 @default.
- W2465860350 cites W2074664341 @default.
- W2465860350 cites W2096027620 @default.
- W2465860350 cites W2100158834 @default.
- W2465860350 cites W2102031533 @default.
- W2465860350 cites W2105660237 @default.
- W2465860350 cites W2118982164 @default.
- W2465860350 cites W2121626779 @default.
- W2465860350 cites W2125616358 @default.
- W2465860350 cites W2128035403 @default.
- W2465860350 cites W2132923173 @default.
- W2465860350 cites W2133075384 @default.
- W2465860350 cites W2135808990 @default.
- W2465860350 cites W2148590804 @default.
- W2465860350 cites W2149441684 @default.
- W2465860350 cites W2152897456 @default.
- W2465860350 cites W2153398168 @default.
- W2465860350 cites W2153712501 @default.
- W2465860350 cites W2154298769 @default.
- W2465860350 cites W2158804744 @default.
- W2465860350 cites W2164001237 @default.
- W2465860350 cites W2219237094 @default.
- W2465860350 cites W2328043056 @default.
- W2465860350 cites W2338494814 @default.
- W2465860350 cites W2418246656 @default.
- W2465860350 cites W2560367415 @default.
- W2465860350 cites W2572174216 @default.
- W2465860350 doi "https://doi.org/10.1056/nejmoa1604958" @default.
- W2465860350 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5007206" @default.
- W2465860350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27433843" @default.
- W2465860350 hasPublicationYear "2016" @default.
- W2465860350 type Work @default.
- W2465860350 sameAs 2465860350 @default.
- W2465860350 citedByCount "2253" @default.
- W2465860350 countsByYear W24658603502016 @default.
- W2465860350 countsByYear W24658603502017 @default.
- W2465860350 countsByYear W24658603502018 @default.
- W2465860350 countsByYear W24658603502019 @default.
- W2465860350 countsByYear W24658603502020 @default.
- W2465860350 countsByYear W24658603502021 @default.
- W2465860350 countsByYear W24658603502022 @default.
- W2465860350 countsByYear W24658603502023 @default.
- W2465860350 crossrefType "journal-article" @default.
- W2465860350 hasAuthorship W2465860350A5001016649 @default.
- W2465860350 hasAuthorship W2465860350A5001061706 @default.
- W2465860350 hasAuthorship W2465860350A5011802426 @default.
- W2465860350 hasAuthorship W2465860350A5016063312 @default.
- W2465860350 hasAuthorship W2465860350A5017076927 @default.
- W2465860350 hasAuthorship W2465860350A5022247782 @default.
- W2465860350 hasAuthorship W2465860350A5023066362 @default.
- W2465860350 hasAuthorship W2465860350A5028356747 @default.
- W2465860350 hasAuthorship W2465860350A5029587873 @default.